453 related articles for article (PubMed ID: 30744686)
41. Variation in receipt of pharmacotherapy for alcohol use disorders across racial/ethnic groups: A national study in the U.S. Veterans Health Administration.
Williams EC; Gupta S; Rubinsky AD; Glass JE; Jones-Webb R; Bensley KM; Harris AHS
Drug Alcohol Depend; 2017 Sep; 178():527-533. PubMed ID: 28728114
[TBL] [Abstract][Full Text] [Related]
42. Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder.
Warren D
FP Essent; 2019 Mar; 478():30-42. PubMed ID: 30844223
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
[TBL] [Abstract][Full Text] [Related]
44. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.
Hagedorn HJ; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Wisdom JP; Harris AH
Implement Sci; 2016 May; 11():64. PubMed ID: 27164835
[TBL] [Abstract][Full Text] [Related]
45. Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Kelty E; Terplan M; Greenland M; Preen D
Drugs; 2021 May; 81(7):739-748. PubMed ID: 33830479
[TBL] [Abstract][Full Text] [Related]
46. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological treatment of alcohol use disorder. Scientific evidence.
Attilia F; Perciballi R; Rotondo C; Capriglione I; Iannuzzi S; Attilia ML; Vitali M; Alessandrini G; Scamporrino MCM; Fiore M; Ceccanti M;
Riv Psichiatr; 2018; 53(3):123-127. PubMed ID: 29912214
[TBL] [Abstract][Full Text] [Related]
48. Disparities in pharmacotherapy for alcohol use disorder in the context of universal health care: a Swedish register study.
Karriker-Jaffe KJ; Ji J; Sundquist J; Kendler KS; Sundquist K
Addiction; 2017 Aug; 112(8):1386-1394. PubMed ID: 28406579
[TBL] [Abstract][Full Text] [Related]
49. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
Muvvala SB; O'Malley SS; Rosenheck R
Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
[TBL] [Abstract][Full Text] [Related]
50. Medications for treating alcohol dependence.
Williams SH
Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
[TBL] [Abstract][Full Text] [Related]
51. Physicians' opinions about medications to treat alcoholism.
Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
[TBL] [Abstract][Full Text] [Related]
52. Alcohol Use Disorder Treatment in Sexually and Gender Diverse Patients: A Retrospective Cohort Study.
McDowell MJ; King DS; Gitin S; Miller AS; Batchelder AW; Busch AB; Greenfield SF; Huskamp HA; Keuroghlian AS
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656181
[No Abstract] [Full Text] [Related]
53. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
54. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
Helton SG; Lohoff FW
Psychiatry Res; 2015 Dec; 230(2):121-9. PubMed ID: 26455758
[TBL] [Abstract][Full Text] [Related]
55. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report.
Terasaki D; Ellinwood A; White D
Subst Abuse Treat Prev Policy; 2024 Feb; 19(1):18. PubMed ID: 38424567
[TBL] [Abstract][Full Text] [Related]
56. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?
Antonelli M; Sestito L; Tarli C; Addolorato G
Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734
[TBL] [Abstract][Full Text] [Related]
57. Supervised disulfiram in the treatment of alcohol use disorder: a commentary.
Krampe H; Spies CD; Ehrenreich H
Alcohol Clin Exp Res; 2011 Oct; 35(10):1732-6. PubMed ID: 21569053
[TBL] [Abstract][Full Text] [Related]
58. Dissemination, adoption, and implementation of acamprosate for treating alcohol use disorders.
Knudsen HK; Roman PM
J Stud Alcohol Drugs; 2014 May; 75(3):467-75. PubMed ID: 24766759
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological Treatment of Alcohol use Disorder in Patients with Psychotic Disorders: A Systematic Review.
Rosenstand NJ; Nielsen AS; Skøt L; Anhøj S; Nielsen DG; Højlund M; Mellentin AI
Curr Neuropharmacol; 2024; 22(6):1129-1143. PubMed ID: 36582063
[TBL] [Abstract][Full Text] [Related]
60. The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review.
Morgane GL; Delphine LG; Guillaume K; Yves LJ
Curr Pharm Des; 2021; 27(23):2737-2745. PubMed ID: 33059563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
